Categories: The Charlton Centre

Do you use the government’s Trillium program in addition to your drug plan?

We are very fortunate in the province of Ontario to have many options for supporting the cost of prescription medications.  At Charlton Health we work with specialty medications that have a high cost.  These medications are paid for through patient’s private insurance plans, government-based plans, and drug company support programs. In some cases, patients use a combination of all three types of coverage. We specialize in coordinating this process.

For patients who have a private plan that has a limit to the amount of drug costs it will cover within a year, it may be necessary to use the government-based Trillium Drug Program to help pay the balance of prescription costs. In this situation, the receipt for the portion of the prescription payment not funded by the private plan will now be submitted to the Trillium website rather than being mailed in. This must be submitted by the patient or a member of their household.

For people using Trillium in addition to their private plan, you will be hearing from our team to provide more details on the new process and payment details.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Ankylosing Spondylitis Awareness Month

Ankylosing Spondylitis Awareness Month, observed each year in May, is one of several health promotion…

1 week ago

Saphnelo for Lupus

Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe…

4 weeks ago

A New Treatment Option for Alopecia Areata

On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral…

1 month ago

Infliximab Now Available As An Injection for Crohn’s and Ulcerative Colitis Patients

Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. …

2 months ago

A New Treatment For Ulcerative Colitis

On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of…

3 months ago

Show Love to your Heart

As February is heart month, today is an excellent occasion to really show why we love our hearts and…

3 months ago